You are here

Home » Content

RENAL REPLASMAN TEDAVİLERİ İÇİN HASTA SEÇİM KRİTERLERİ

CRITERIA OF PATIENT SELECTION FOR RENAL REPLACEMENT THERAPIES

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 1999

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The criteria indicating the suitability of the end-stage renal disease patients for renal replacement therapy(RRT) are still controversial. However, patient selection is a very important factor determining survival on RRT. In addition, 2-4% of the national budget for healthy care are spent for these therapies in developed countries. Therefore, the determination of the admittance criteria for these therapies are important. If various reports about this issue are analysed, it may be suggested that serious uraemic symptoms and signs associated with impaired renal functions should be taken into account for patient selection to RRT.
Bookmark/Search this post with
Abstract (Original Language): 
Son dönem kronik böbrek yetmezliğinde renal replasman tedavisine(RRT) başlama kriterleri halen tartışmalıdır. Oysa hasta seçimi survivali etkileyen önemli faktörlerden birisidir. Ayrıca gelişmiş ülkelerde ulusal sağlık bütçesinin %2-4'ü bu tedavilere ayrılmaktadır. Bu nedenlerle RRT için hasta seçim kriterlerinin belirlenmesi önemlidir. Çeşitli araştırma raporları incelendiğinde RRT için hasta seçiminde azalmış renal fonksiyonla birlikte ciddi üremik semptom ve bulguların da göz önüne alınması gerektiği söylenebilir.
FULL TEXT (PDF): 
PDF icon pdf_tndt_242.pdf
  • 2
51-55
  • Turkish

REFERENCES

References: 

1. MallickNP, Gokal R Hemodialysis. The Lancet 1999; 353:737-742.
2.
Locatell
i F, Vecchio LD, Manzoni C. Morbidity and mortality on maintenance haemodialysis. Nephron 1998,80:380-400.
3.
Ere
k E, Süleymanlar G, Serdengeçti K. Türkiye'de Nefroloji-Diyaliz ve Transplantasyon (Registry-1997), Tayf ofset, İstanbul-Türkiye, 1998, ss:l-47.
4. Lazarus JM, Denker BM, Owen WF. Hemodialysis. In:Brenner BM(ed.) The Kidney. WB Saunders Co. ,
Philadelphia-Pennsylvania, 1996, pp:2426-2427.
5. Stone WJ, Hakim RM. Therapeutic options in the management of end-stage renal disease. In: Jacobson HR, Striker GE, Klahr S. The Principles and Practice of Nephrology. Mosby -Year Book, Inc. St.Louis-Missouri, 1995, pp: 652-654.
6. Warnock DG. Chronic renal failure. In:Bennett JC, Plum F(eds.) Cecil Textbook of Medicine, WB
Saunders Co, Philadelphia, 1996, p:563.
7. Zawada ET. Indications for Dialysis. In: Daugirdas JT, Ing TS(eds.) Handbook of Dialysis, Little-Brown,
Co.,USA, 1994, p.3-5.
8. Ross EA, Barri YMH. Hemodialysis. In:Tisher CC,
Wilcox CS(eds.) Nephrology, Williams-Wilkins,
Baltimore-Maryland,USA, 1995, p:228.
54
9. Carpenter CB, Lazarus JM. Dialysis and Transplantation in the treatment of Renal Failure. IniFauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL(eds.) Harrison's Principles of Internal Medicine, Me Graw Hill,Co, USA, 1998, p:1520.
10. Rolin III HA, Hall PM. Evaluation of glomerular filtration rate and renal plasma flow. In: Jacobson HR, Striker GE, Klahr S(eds.) The Principles and Practice of Nephrology, Mosby-Year book, Inc., St.Louis,Missouri, 1995, pp:8-l 1.
11. Markell MS, Friedman EA. Diabetic Nephropathy: End-Stage. In: DeFronzo RA(ed.) Current Therapy of
Diabetes Mellitus, Mosby-Year Book,Inc. St.Louis, Missouri, 1998, p: 145.
12. Maeda K. The current state of dialysis therapy in Japan.
Asian Med J 40(1): 1-7, 1997.
13. Gokal R, Mallick NP. Peritoneal Dialysis. The Lancet
1999;353:823-828.
14. Glassock RJ, Cecka JM. Long-term outcome of renal transplantation. In:Massry SG, Glassock RJ(eds.)Textbook of Nephrology, Williams-Wilkins, Baltimore- Maryland-USA, 1995, pp: 1718-1727.
15. Klinkmann H, Vienken J. Membranes for dialysis.
Nephrol Dial Transplant 1995; 10 (Suppl.3):39-45.
55

Thank you for copying data from http://www.arastirmax.com